PL1667662T3 - Dostarczanie leków poprzez śluzówkę jamy ustnej - Google Patents

Dostarczanie leków poprzez śluzówkę jamy ustnej

Info

Publication number
PL1667662T3
PL1667662T3 PL04768358T PL04768358T PL1667662T3 PL 1667662 T3 PL1667662 T3 PL 1667662T3 PL 04768358 T PL04768358 T PL 04768358T PL 04768358 T PL04768358 T PL 04768358T PL 1667662 T3 PL1667662 T3 PL 1667662T3
Authority
PL
Poland
Prior art keywords
lozenge
drug delivery
stable
buccal drug
crystallising sugar
Prior art date
Application number
PL04768358T
Other languages
English (en)
Inventor
Anders Dam
Janos Major
Peter Tasko
Original Assignee
Gelmedic Holding Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelmedic Holding Aps filed Critical Gelmedic Holding Aps
Publication of PL1667662T3 publication Critical patent/PL1667662T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL04768358T 2003-09-05 2004-09-06 Dostarczanie leków poprzez śluzówkę jamy ustnej PL1667662T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0320854.3A GB0320854D0 (en) 2003-09-05 2003-09-05 Buccal drug delivery
GBGB0403373.4A GB0403373D0 (en) 2003-09-05 2004-02-16 Buccal drug delivery
EP04768358A EP1667662B1 (en) 2003-09-05 2004-09-06 Buccal drug delivery
PCT/GB2004/003811 WO2005023226A1 (en) 2003-09-05 2004-09-06 Buccal drug delivery

Publications (1)

Publication Number Publication Date
PL1667662T3 true PL1667662T3 (pl) 2008-10-31

Family

ID=34276828

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04768358T PL1667662T3 (pl) 2003-09-05 2004-09-06 Dostarczanie leków poprzez śluzówkę jamy ustnej

Country Status (22)

Country Link
US (4) US8343532B2 (pl)
EP (2) EP1938806A1 (pl)
JP (2) JP5303111B2 (pl)
CN (1) CN1845724B (pl)
AT (1) ATE392888T1 (pl)
AU (1) AU2004269968B2 (pl)
BR (1) BRPI0414178A (pl)
CA (1) CA2537797C (pl)
CY (1) CY1108207T1 (pl)
DE (1) DE602004013348T2 (pl)
DK (1) DK1667662T3 (pl)
ES (1) ES2305842T3 (pl)
GB (2) GB0320854D0 (pl)
HR (1) HRP20080289T3 (pl)
IL (1) IL173998A0 (pl)
NO (1) NO20061525L (pl)
NZ (1) NZ545673A (pl)
PL (1) PL1667662T3 (pl)
PT (1) PT1667662E (pl)
SI (1) SI1667662T1 (pl)
WO (1) WO2005023226A1 (pl)
ZA (1) ZA200601902B (pl)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
EP2462926B1 (en) * 2006-05-23 2015-12-30 Orahealth Corporation Bi-layer oral adhering tablet with acacia gum adhesive
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
GB2453770A (en) * 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
US9023322B2 (en) 2008-03-26 2015-05-05 Stichting Sanammad Chewing gum compositions comprising cannabinoids
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
EP2437730A4 (en) * 2009-05-20 2014-02-26 Lingual Consegna Pty Ltd ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION
GB0920041D0 (en) * 2009-11-16 2009-12-30 Univ Aston Tablet
US9775376B2 (en) * 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
KR101274779B1 (ko) * 2010-12-08 2013-06-25 주식회사 삼양제넥스 당 코팅 차전자피 함유 분말 조성물
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) * 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US12285025B2 (en) 2012-02-10 2025-04-29 R.J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9789061B2 (en) * 2012-02-19 2017-10-17 Orahealth Corp. Acacia gum adhesive with calcium carbonate for oral adhering discs
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
AU2016280161B2 (en) * 2015-06-19 2019-02-21 Harrow Ip, Llc Pharmaceutical compositions for anesthesiological applications
US10391102B2 (en) 2015-06-19 2019-08-27 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10555952B2 (en) 2015-06-19 2020-02-11 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US20200297734A1 (en) 2015-06-19 2020-09-24 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
CN113784704A (zh) * 2019-04-17 2021-12-10 诺狄更斯公司 快速崩解大麻素片剂
US12213510B2 (en) 2019-09-11 2025-02-04 Nicoventures Trading Limited Pouched products with enhanced flavor stability
US12342847B2 (en) 2019-09-11 2025-07-01 Nicoventures Trading Limited Oral product with cellulosic flavor stabilizer
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
JP2023505351A (ja) 2019-12-09 2023-02-08 ニコベンチャーズ トレーディング リミテッド 口腔用組成物のための薬剤
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US12691059B2 (en) 2019-12-09 2026-07-28 Nicoventures Trading Limited Oral composition with polymeric component
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US12491250B2 (en) 2019-12-09 2025-12-09 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US12151023B2 (en) 2019-12-09 2024-11-26 Nicoventures Trading Limited Oral composition with beet material
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
US12550928B2 (en) 2019-12-09 2026-02-17 Nicoventures Trading Limited Liquid oral composition
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US12171872B2 (en) 2019-12-09 2024-12-24 Nicoventures Trading Limited Oral compositions and methods of manufacture
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US12599160B2 (en) 2019-12-09 2026-04-14 Nicoventures Trading Limited Lipid-containing oral composition
US20230107491A1 (en) * 2020-01-30 2023-04-06 Purcann Pharma Inc. Method for preventing or reducing cannabaceae biomass decomposition
JP2023530239A (ja) 2020-06-08 2023-07-14 ニコベンチャーズ トレーディング リミテッド 発泡性口腔組成物
US20220110900A1 (en) * 2020-10-09 2022-04-14 Nutrient Density Technology, LLC Solid nutrient compositions and associated methods
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
US12382982B2 (en) 2021-06-25 2025-08-12 Nicoventures Trading Limited Oral products and method of manufacture
CN119789793A (zh) 2021-07-30 2025-04-08 尼科凡图尔斯贸易有限公司 包含微晶纤维素的气溶胶发生基材
JP2024536230A (ja) 2021-09-30 2024-10-04 ニコベンチャーズ トレーディング リミテッド 塩基性アミン及びイオン対形成剤を含む口腔用製品
EP4408184A1 (en) 2021-09-30 2024-08-07 Nicoventures Trading Limited Oral gum composition
EP4611751A1 (en) * 2022-11-03 2025-09-10 NIC NAC Naturals, LLC Composition and method for controlled human nicotine absorption without ph adjusters
CN116114905A (zh) * 2023-02-09 2023-05-16 东莞市吉纯生物技术有限公司 一种具有保湿功能的口含制品及其制备方法和应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1571522A1 (de) 1966-12-16 1970-07-23 Gebefuegi Dipl Ing Istvan Verfahren und Herstellung von Formkoerpern fuer Bauund Isolierzwecke aus geblaehtem Perlit oder Vermikulit
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
GB2049417B (en) 1979-05-29 1983-06-15 Mitra A K Extended release antiacid lozenges
US4614654A (en) * 1984-08-24 1986-09-30 Wm. Wrigley Jr. Company Taffy-like chewing gum confection and method
DK161428C (da) * 1985-05-10 1991-12-16 Fertin Lab As Fast, oralt cariesmodvirkende middel
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
JPS62298528A (ja) * 1986-06-16 1987-12-25 Yutaka Mizushima 咽頭痛治療トロ−チ
JP2522772B2 (ja) 1986-08-19 1996-08-07 太陽誘電株式会社 Ｗをド―プしたＴｉＯ２単結晶粒子とその製造方法
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
DK615689A (da) * 1989-11-07 1991-05-08 Anders Dam Rygesupplement eller rygeerstatningsprodukt
US5156845A (en) * 1990-05-04 1992-10-20 Colgate-Palmolive Company Dry mouth lozenge
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
WO1995017829A1 (en) * 1993-12-29 1995-07-06 Wm. Wrigley Jr. Company Liquid sorbitol/mannitol/glycerin blend and compositions containing same
US5651936A (en) * 1993-12-29 1997-07-29 Wm. Wrigley Jr. Company Syrups containing sorbitol, a plasticizing agent and an anticrystallization agent and their use in chewing gum and other products
MA23587A1 (fr) 1994-06-23 1995-12-31 Procter & Gamble Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
SK74396A3 (en) 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
US5762961A (en) 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
DE19606968C2 (de) 1996-02-24 1998-07-09 Suedzucker Ag Verwendung von 1,1-GPS in Hartkaramellen
WO1997038679A2 (en) 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
TR199802305T2 (xx) * 1996-05-13 2002-06-21 Norvartis Consumer Health S.A. Yanaktan uygulama y�ntemi.
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
WO2000051582A2 (en) * 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
GB2352051A (en) * 1999-07-14 2001-01-17 Taiko Denki Co Ltd Two part cable connectors
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
EP1231900A1 (en) 1999-11-23 2002-08-21 The Robert Gordon University Bilayered buccal tablets comprising nicotine
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
NZ528167A (en) 2001-03-26 2005-04-29 Smithkline Beecham Corp Nicotine-containing oral dosage form
WO2002085119A1 (en) 2001-04-20 2002-10-31 Lavipharm Laboratories Inc. Intraoral delivery of nicotine for smoking cessation
MXPA04002973A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosis de liberacion modificada.
US20040037879A1 (en) 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
US20040101543A1 (en) * 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
US20030185884A1 (en) * 2002-04-01 2003-10-02 Singh Nikhilesh Nihala Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
UA79281C2 (en) * 2002-04-03 2007-06-11 Solvay Pharm Bv Stabilized composition comprising a natural cannabinoid compound and process for the preparation thereof
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery

Also Published As

Publication number Publication date
CN1845724A (zh) 2006-10-11
DE602004013348D1 (de) 2008-06-05
US20130085165A1 (en) 2013-04-04
EP1667662A1 (en) 2006-06-14
US20130087946A1 (en) 2013-04-11
EP1667662B1 (en) 2008-04-23
ATE392888T1 (de) 2008-05-15
BRPI0414178A (pt) 2006-10-31
US20140054826A1 (en) 2014-02-27
CN1845724B (zh) 2015-05-13
CA2537797C (en) 2011-10-25
NZ545673A (en) 2009-03-31
WO2005023226A1 (en) 2005-03-17
CY1108207T1 (el) 2014-02-12
US8603517B2 (en) 2013-12-10
JP2007504207A (ja) 2007-03-01
GB0320854D0 (en) 2003-10-08
GB0403373D0 (en) 2004-03-17
HRP20080289T3 (hr) 2008-08-31
SI1667662T1 (sl) 2008-10-31
EP1938806A1 (en) 2008-07-02
JP5303111B2 (ja) 2013-10-02
DK1667662T3 (da) 2008-08-25
US8603516B2 (en) 2013-12-10
US20070081949A1 (en) 2007-04-12
CA2537797A1 (en) 2005-03-17
AU2004269968B2 (en) 2009-11-12
NO20061525L (no) 2006-06-06
ZA200601902B (en) 2007-09-26
AU2004269968A1 (en) 2005-03-17
US8858984B2 (en) 2014-10-14
ES2305842T3 (es) 2008-11-01
DE602004013348T2 (de) 2009-11-19
US8343532B2 (en) 2013-01-01
PT1667662E (pt) 2008-07-15
IL173998A0 (en) 2006-07-05
JP2013064005A (ja) 2013-04-11

Similar Documents

Publication Publication Date Title
GB0403373D0 (en) Buccal drug delivery
MXPA02010525A (es) Formulaciones de goma de mascara con cubierta que incluyen centro tableteado.
ZA200606173B (en) Effervescent oral opiate dosage form
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
WO2003030829A3 (en) Liposome-encapsulated insulin formulations
GB0122318D0 (en) Organic compounds
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
EP1082106A4 (en) SUBLINGUAL ORAL EFFERVESCENT AGENT
WO2004021869A3 (en) Systems and methods for moving and/or restraining tissue in the upper respiratory system
WO2005044199A3 (en) Combination of proton pump inhibitor and sleep aid
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
WO2003072195A3 (en) Method for administering glp-1 molecules
NO20030365L (no) Fentanylpreparat for nasal administrering
AU2003217820A1 (en) Periocular drug delivery for diabetic retinopathy
WO2005018605A3 (en) Novel formulation of ropinirole
NO20073551L (no) Nikotinacetylkolinreseptorligander
HK1045113A1 (zh) 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式
WO2004066983A3 (en) Controlled release of highly soluble agents
TW200511999A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
WO2006017540A3 (en) Pilocarpine compositions and methods of use thereof
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
TW200626141A (en) Crystalline form of a drug
MY141008A (en) Oral formulations of deoxypeganine and their uses
NO20054034L (no) Fremgangsmate for behandling av hypotyroidisme.